First-Line Immunotherapy for Non–Small-Cell Lung Cancer

Martin Reck, Jordi Remón, Matthew David Hellmann

View at source ↗Review896 citations
The abstract is not reproduced here because its license does not permit redistribution. Read it at the original source.

Record

Archive ID
doi:10.1200/jco.21.01497
Published
Jan 5, 2022
Venue
Journal of Clinical Oncology
DOI
10.1200/jco.21.01497
PubMed
34985920
Categories
Cancer Immunotherapy and Biomarkers
Provenance
openalex

Topics